A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02059616
Recruitment Status : Unknown
Verified April 2014 by CJ HealthCare Corporation.
Recruitment status was:  Recruiting
First Posted : February 11, 2014
Last Update Posted : April 30, 2014
Information provided by (Responsible Party):
CJ HealthCare Corporation

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2015
  Estimated Study Completion Date : December 2015